← Back to guidelines
Vascular Surgery12 papers

Erysipelas

Last edited: 4/15/2026

Overview

Erysipelas is a superficial skin infection characterized by well-demarcated erythematous plaques, typically caused by Streptococcus pyogenes. It often affects the lower extremities and can be complicated by impaired lymphatic function, especially post-surgical interventions like saphenectomy 1.

Diagnosis

  • Clinical Presentation: Well-demarcated, raised, erythematous rash with systemic symptoms like fever 13.
  • Laboratory Tests: Elevated C-reactive protein (CRP) and neutrophil levels may indicate a more complicated course 2.
  • Imaging: Lymphoscintigraphy can reveal dermal reflux and lymph node involvement in post-saphenectomy patients 1.
  • Management

  • First-Line Antibiotics: Cefuroxime or clindamycin are commonly used initial treatments 2.
  • Adjunctive Measures: Warm compresses for localized warmth and swelling; systemic antibiotics adjusted based on clinical response and laboratory parameters 2.
  • Specific Considerations: For bullous or hemorrhagic forms, consider broader spectrum antibiotics or alternative agents 2.
  • Special Populations

  • Comorbidities: Patients with stasis dermatitis or chronic venous insufficiency may have a reduced response to initial therapy, necessitating closer monitoring and potentially adjusted antibiotic regimens 2.
  • Nephrotic Syndrome: Patients may present with atypical manifestations; aqueous penicillin can be effective 3.
  • Key Recommendations

  • Monitor lymphoscintigraphic changes in patients undergoing saphenectomy who develop erysipelas to assess lymphatic impairment 1 (Evidence: Moderate).
  • In patients with bullous or hemorrhagic erysipelas, chronic venous insufficiency, or stasis dermatitis, anticipate a reduced response to standard antibiotic therapy and consider broader spectrum antibiotics 2 (Evidence: Moderate).
  • For erysipelas in patients with nephrotic syndrome, aqueous penicillin can be an effective treatment option 3 (Evidence: Weak).
  • References

    1 Quilici Belczak CE, Pereira de Godoy JM, Quilici Belczak S, de Moraes Silva MA, Caffaro RA. Erysipelas as an aggravating factor for impaired lymphatics in saphenectomy patients. International angiology : a journal of the International Union of Angiology 2017. link 2 Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2015. link 3 Varghese R, Melo JC, Chun CH, Raff MJ. Erysipelas-like syndrome caused by Streptococcus pneumoniae. Southern medical journal 1979. link

    Original source

    1. [1]
      Erysipelas as an aggravating factor for impaired lymphatics in saphenectomy patients.Quilici Belczak CE, Pereira de Godoy JM, Quilici Belczak S, de Moraes Silva MA, Caffaro RA International angiology : a journal of the International Union of Angiology (2017)
    2. [2]
      Risk factors associated with a reduced response in the treatment of erysipelas.Linke M, Booken N Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2015)
    3. [3]
      Erysipelas-like syndrome caused by Streptococcus pneumoniae.Varghese R, Melo JC, Chun CH, Raff MJ Southern medical journal (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG